Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries

Table 1 Underlying conditions and associated crude mortality rates in 63 paediatric patients with invasive mucormycosis

Underlying conditions	Cases (%)	Mortality (%)^f
Haematological malignancies^a	29 (46)	9/23 (39.1)
HSCT^b	10 (15.9)	8/10 (80)
SOT^c	3 (4.8)	2/2
Other malignancies^d	4 (6.3)	0/3
Diabetes mellitus	3 (4.8)	0/2
Other conditions^e	5 (7.9)	0/4
Trauma/surgery	3 (4.8)	1/3
None	6 (9.5)	1/6

^a Acute lymphoblastic leukaemia (ALL), acute myeloid leukaemia (AML), Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), myelodysplastic syndrome
^b haematopoietic stem cell transplantation
^c solid organ transplantation
^d Osteosarcoma, thoracic and brain tumour
^e Hyposplenism, Pearson syndrome, aplastic anaemia, systemic lupus erythematosus
^f In 10 patients (15.8%) mortality rates were not recorded due to lost to follow up

ISSN: 1471-2334